Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.
Feature The Material Code. Machine-learning techniques could revolutionize how materials science is done. Silent no more Article Direct detection of the 229Th nuclear clock transition Principles underlying sensory map topography in primary visual cortex Research News Continuous evolution of Bacillus thuringiensis toxins overcomes insect resistance Letter Resolved atomic lines reveal outflows in two ultraluminous X-ray sources Polar metals by geometric design Machine-learning-assisted materials discovery using failed experiments Scalable and sustainable electrochemical allylic C–H oxidation Chondritic xenon in the Earth’s mantle The genetic program for cartilage development has deep homology within Bilateria Topology of ON and OFF inputs in visual cortex enables an invariant columnar architecture Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression Unique human immune signature of Ebola virus disease in Guinea A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells Ubiquitination independent of E1 and E2 enzymes by bacterial effectors Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9 Toolbox The Struggle with Image Glut Futures The Museum Of Nothing A sense of enterprise The leap to industry Academic return Engagement upgrade Bavarian biotech Building an innovator The geography of discovery Donor drugs Comment Industry-funded academic inventions boost innovation Starting up and spinning out: The changing nature of partnerships between pharma and academia aligning needs Pioneering government-sponsored drug repositioning collaborations: progress and learning Why we need risk innovation